title: From amprenavir to GW433908.
authors.affiliation: Infectious Diseases Unit, Hospital Clinic I Provincial de Barcelona, Villarreol 170, E-08036 Barcelona, Spain. gatell@medicina.ub.es
authors.forename: J M
authors.initials: JM
authors.lastname: Gatell
mesh_terms: D019380:Anti-HIV Agents / Q000627:therapeutic use*; D002219:Carbamates; D002986:Clinical Trials as Topic; D024882:Drug Resistance, Viral; D005663:Furans; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D010755:Organophosphates; D011355:Prodrugs / Q000493:pharmacokinetics / Q000627:therapeutic use*; D013449:Sulfonamides / Q000493:pharmacokinetics / Q000627:therapeutic use*
chemical_list: D019380:Anti-HIV Agents; D002219:Carbamates; D005663:Furans; D010755:Organophosphates; D011355:Prodrugs; D013449:Sulfonamides; C095108:amprenavir; C426859:fosamprenavir